Ignite Creation Date:
2024-07-17 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06471205
Status:
RECRUITING
Last Update Posted:
2024-06-27
First Post:
2024-06-18
Brief Title:
A Study of BL-B01D1PD-1 Monoclonal Antibody in Patients With Unresectable Locally Advanced or Recurrent Metastatic Triple-negative Breast Cancer
Sponsor:
Sichuan Baili Pharmaceutical Co Ltd
Organization:
Sichuan Baili Pharmaceutical Co Ltd
Organization Data
Organization:
Sichuan Baili Pharmaceutical Co Ltd
Class:
INDUSTRY
Study ID:
BL-B01D1-204-04
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sichuan Baili Pharmaceutical Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Baili-Bio Chengdu Pharmaceutical Co Ltd | INDUSTRY |